Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
611.00
+10.00 (1.66%)
At close: Dec 2, 2024, 1:30 PM CST
54.10%
Market Cap 119.20B
Revenue (ttm) 40.47M
Net Income (ttm) -545.92M
Shares Out 154.61M
EPS (ttm) -2.72
PE Ratio n/a
Forward PE 74.75
Dividend n/a
Ex-Dividend Date n/a
Volume 622,615
Average Volume 350,070
Open 604.00
Previous Close 601.00
Day's Range 592.00 - 628.00
52-Week Range 240.50 - 800.00
Beta 0.70
RSI 70.37
Earnings Date May 9, 2025

About TPE:6919

Caliway Biopharmaceuticals Co., Ltd. engages in the development of drugs for aesthetic medicine and chronic inflammation. The company was incorporated in 2012 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6919
Full Company Profile

Financial Performance

In 2024, TPE:6919's revenue was 44.43 million, an increase of 14.13% compared to the previous year's 38.93 million. Losses were -588.83 million, 20.5% more than in 2023.

Financial Statements

News

There is no news available yet.